06 Nov, EOD - Indian

SENSEX 80378.13 (1.13)

Nifty 50 24484.05 (1.12)

Nifty Bank 52317.4 (0.21)

Nifty IT 42039.5 (3.99)

Nifty Midcap 100 57355.8 (2.21)

Nifty Next 50 71389.8 (2.28)

Nifty Pharma 22920.35 (1.14)

Nifty Smallcap 100 18906.1 (2.18)

06 Nov, EOD - Global

NIKKEI 225 39480.67 (2.61)

HANG SENG 20538.38 (-2.23)

S&P 5952.75 (2.21)

Login/Signup

You are Here : Home > Research

06-Nov-2024

Dr Reddys Laboratories

Sales up 16.45% and NP down 15.28%

'On consolidated basis

Quarter ended September 2024 compared with Quarter ended September 2023.

Net sales (including other operating income) of Dr Reddys Laboratories has increased 16.45% to Rs 8038.2 crore.  Sales of Pharmaceutical Services segment has gone up 16.26% to Rs 1,119.00 crore (accounting for 13.48% of total sales).  Sales of Global Generics segment has gone up 17.19% to Rs 7,163.60 crore (accounting for 86.30% of total sales).  Sales of Others segment has gone down 73.79% to Rs 17.90 crore (accounting for 0.22% of total sales).  Inter-segment sales rose Rs 241.20 crore to Rs 262.30 crore.  

Profit before interest, tax and other unallocable items (PBIT) has jumped 18.32% to Rs 4,777.20 crore.  PBIT of Pharmaceutical Services segment rose 100.08% to Rs 252.10 crore (accounting for 5.28% of total PBIT).  PBIT of Global Generics segment rose 16.18% to Rs 4,516.20 crore (acco...



Pleaselogin & subscribe to view the full report.

More Reports
More Reports View Company Information